Patents by Inventor Todd J. Sheldon

Todd J. Sheldon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11253707
    Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.
    Type: Grant
    Filed: October 14, 2019
    Date of Patent: February 22, 2022
    Assignee: Medtronic, Inc.
    Inventors: Hyun J. Yoon, Wade M. Demmer, Matthew J. Hoffman, Robert A. Betzold, Jonathan D. Edmonson, Michael L. Ellingson, Mark K. Erickson, Ben W. Herberg, Juliana E. Pronovici, James D. Reinke, Todd J. Sheldon, Paul R. Solheim
  • Patent number: 11229795
    Abstract: Cardiac resynchronization therapy (CRT) delivered to a heart of a patient may be adjusted based on detection of a surrogate indication of the intrinsic atrioventricular conduction of the heart. In some examples, the surrogate indication is determined to be a sense event of the first depolarizing ventricle of the heart within a predetermined period of time following the delivery of a fusion pacing stimulus to the later depolarizing ventricle. In some examples, the CRT is switched from a fusion pacing configuration to a biventricular pacing configuration if the surrogate indication is not detected, and the CRT is maintained in a fusion pacing configuration if the surrogate indication is detected.
    Type: Grant
    Filed: October 18, 2019
    Date of Patent: January 25, 2022
    Assignee: Medtronic, Inc.
    Inventors: Aleksandre Sambelashvili, Thomas J. Mullen, Todd J. Sheldon
  • Publication number: 20210401350
    Abstract: An implantable medical device is configured to determine a first atrial arrhythmia score from ventricular events sensed by a sensing circuit of an implantable medical device and determine a second atrial arrhythmia score from an intraventricular signal comprising atrial mechanical event signals attendant to atrial systole and produced by a sensor of the implantable medical device. An atrial arrhythmia is detected based on the first atrial arrhythmia score and the second atrial arrhythmia score.
    Type: Application
    Filed: September 14, 2021
    Publication date: December 30, 2021
    Inventors: Shantanu SARKAR, Wade M. DEMMER, Todd J. SHELDON, Vincent E. SPLETT
  • Patent number: 11207526
    Abstract: A medical device is configured to produce a cardiac motion signal by sampling a signal produced by an axis of a motion sensor, starting a blanking period, suspending the sampling of the signal during at least a portion of the blanking period, and restarting the sampling of the signal at the sampling frequency before the blanking period has expired. The medical device may detect a cardiac event from the cardiac motion signal and generate a pacing pulse in response to detecting the cardiac event in some examples.
    Type: Grant
    Filed: November 12, 2019
    Date of Patent: December 28, 2021
    Assignee: Medtronic, Inc.
    Inventors: Todd J. Sheldon, Vincent P. Ganion, Greggory R. Herr, Michael L. Hudziak, Juliana E. Pronovici, Paul R. Solheim
  • Patent number: 11185701
    Abstract: An intracardiac ventricular pacemaker having a motion sensor, a pulse generator and a control circuit coupled to the pulse generator and the motion sensor is configured to identify a ventricular systolic event, detect a ventricular passive filling event signal from the motion signal, and determine a time interval from the ventricular systolic event to the ventricular passive filling event. The pacemaker establishes a minimum pacing interval based on the time interval.
    Type: Grant
    Filed: April 9, 2018
    Date of Patent: November 30, 2021
    Assignee: Medtronic, Inc.
    Inventors: Wade M. Demmer, Juliana E. Pronovici, Todd J. Sheldon
  • Publication number: 20210353946
    Abstract: An intracardiac pacemaker system is configured to produce physiological atrial event signals by a sensing circuit of a ventricular intracardiac pacemaker and select a first atrial event input as the physiological atrial event signals. The ventricular intracardiac pacemaker detects atrial events from the selected first atrial event input, determines if input switching criteria are met, and switches from the first atrial event input to a second atrial event input in response to the input switching criteria being met. The second atrial event input includes broadcast atrial event signals produced by a second implantable medical device and received by the ventricular intracardiac pacemaker.
    Type: Application
    Filed: August 2, 2021
    Publication date: November 18, 2021
    Inventors: Wade M. DEMMER, Yong K. CHO, Mark K. ERICKSON, Todd J. SHELDON
  • Publication number: 20210330983
    Abstract: An implantable medical device includes an activity sensor, a pulse generator, and a control module. The control module is configured to determine activity metrics from the activity signal and determine an activity metric value at a predetermined percentile of the activity metrics. The control module sets a lower pacing rate set point based on the activity metric value at the predetermined percentile.
    Type: Application
    Filed: July 7, 2021
    Publication date: October 28, 2021
    Inventors: Todd J. Sheldon, Wade M. Demmer, Karen J. Kleckner, Douglas A. Peterson, Paul R. Solheim
  • Publication number: 20210308465
    Abstract: A medical device includes a motion sensor configured to sense a motion signal. The medical device includes a control circuit configured to determine at least one ventricular event metric from the motion signal sensed over multiple of atrial cycles, determine that the ventricular event metric meets atrioventricular block criteria and generate an output in response to determining the atrioventricular block.
    Type: Application
    Filed: April 2, 2021
    Publication date: October 7, 2021
    Inventors: Michelle M. GALARNEAU, Vincent P. GANION, Saul E. GREENHUT, Yanina GRINBERG, Todd J. SHELDON, Paul R. SOLHEIM, Hyun J. YOON
  • Patent number: 11123005
    Abstract: An implantable medical device is configured to determine a first atrial arrhythmia score from ventricular events sensed by a sensing circuit of an implantable medical device and determine a second atrial arrhythmia score from an intraventricular signal comprising atrial mechanical event signals attendant to atrial systole and produced by a sensor of the implantable medical device. An atrial arrhythmia is detected based on the first atrial arrhythmia score and the second atrial arrhythmia score.
    Type: Grant
    Filed: November 12, 2018
    Date of Patent: September 21, 2021
    Assignee: Medtronic, Inc
    Inventors: Shantanu Sarkar, Wade M. Demmer, Todd J. Sheldon, Vincent E. Splett
  • Publication number: 20210283402
    Abstract: An implantable medical device system receives a cardiac electrical signal produced by a patient's heart and comprising atrial P-waves and delivers a His bundle pacing pulse to the patient's heart via a His pacing electrode vector. The system determines a timing of a sensed atrial P-wave relative to the His bundle pacing pulse and determines a type of capture of the His bundle pacing pulse in response to the determined timing of the atrial P-wave.
    Type: Application
    Filed: May 17, 2021
    Publication date: September 16, 2021
    Inventors: Todd J. SHELDON, Elizabeth A. MATTSON, Eric R. WILLIAMS
  • Patent number: 11103186
    Abstract: An implantable medical device system includes a pacemaker and an implantable cardioverter defibrillator (ICD). The pacemaker is configured to confirm a hemodynamically unstable rhythm based on an activity metric determined from an activity sensor signal after detecting a ventricular tachyarrhythmia and withhold anti-tachycardia pacing (ATP) pulses in response to confirming the hemodynamically unstable rhythm. The pacemaker may deliver ATP when a hemodynamically unstable rhythm is not confirmed based on the activity metric. The ICD is configured to detect the ATP and withhold a shock therapy in response to detecting the ATP in some examples.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: August 31, 2021
    Assignee: Medtronic, Inc.
    Inventors: Todd J. Sheldon, Wade M. Demmer, Teresa A. Whitman
  • Publication number: 20210236826
    Abstract: A medical device includes a motion sensor configured to produce a motion signal and a control circuit configured to sense atrial events from the motion signal. In some examples, the control circuit is configured to set a ventricular diastolic event window and set a threshold amplitude during the ventricular diastolic event window for sensing an atrial event in response to the motion signal crossing the threshold amplitude during the ventricular diastolic window. The control circuit may determine a maximum amplitude of the motion signal during the ventricular diastolic event window for multiple ventricular cycles and determine an amplitude metric based on at least a portion of the determined maximum amplitudes. The control circuit may determine a target value of the threshold amplitude based on at least the amplitude metric and adjust the threshold amplitude toward the target value.
    Type: Application
    Filed: January 27, 2021
    Publication date: August 5, 2021
    Inventors: Todd J. SHELDON, Paul R. SOLHEIM, Vincent E. SPLETT
  • Publication number: 20210236828
    Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.
    Type: Application
    Filed: April 19, 2021
    Publication date: August 5, 2021
    Inventors: Hyun J. Yoon, Wade M. Demmer, Matthew J. Hoffman, Robert A. Betzold, Jonathan D. Edmonson, Michael L. Ellingson, Ben W. Herberg, Juliana E. Pronovici, James D. Reinke, Todd J. Sheldon, Paul R. Solheim
  • Publication number: 20210236825
    Abstract: A medical device includes a motion sensor configured to produce a motion signal and a control circuit configured to set sensing control parameters and sense atrial events from the motion signal during ventricular cycles according to the sensing control parameters. In some examples, the control circuit is configured to determine a feature of the motion signal for at least some ventricular cycles, determine a metric of the motion signal based on the determined features, and adjust at least one of the sensing control parameters based on the metric.
    Type: Application
    Filed: January 27, 2021
    Publication date: August 5, 2021
    Inventors: Todd J. SHELDON, Keelia M. Escalante, Greggory R. HERR, Juliana E. PRONOVICI, Vincent E. SPLETT
  • Patent number: 11077307
    Abstract: An intracardiac pacemaker system is configured to produce physiological atrial event signals by a sensing circuit of a ventricular intracardiac pacemaker and select a first atrial event input as the physiological atrial event signals. The ventricular intracardiac pacemaker detects atrial events from the selected first atrial event input, determines if input switching criteria are met, and switches from the first atrial event input to a second atrial event input in response to the input switching criteria being met. The second atrial event input includes broadcast atrial event signals produced by a second implantable medical device and received by the ventricular intracardiac pacemaker.
    Type: Grant
    Filed: June 24, 2019
    Date of Patent: August 3, 2021
    Assignee: Medtronic, Inc.
    Inventors: Wade M. Demmer, Yong K. Cho, Mark K. Erickson, Todd J. Sheldon
  • Patent number: 11007369
    Abstract: An implantable medical device system receives a cardiac electrical signal produced by a patient's heart and comprising atrial P-waves and delivers a His bundle pacing pulse to the patient's heart via a His pacing electrode vector. The system determines a timing of a sensed atrial P-wave relative to the His bundle pacing pulse and determines a type of capture of the His bundle pacing pulse in response to the determined timing of the atrial P-wave.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: May 18, 2021
    Assignee: Medtronic, Inc.
    Inventors: Todd J. Sheldon, Elizabeth A. Mattson, Eric R. Williams
  • Patent number: 10981010
    Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.
    Type: Grant
    Filed: May 13, 2019
    Date of Patent: April 20, 2021
    Assignee: Medtronic, Inc.
    Inventors: Hyun J. Yoon, Wade M. Demmer, Matthew J. Hoffman, Robert A. Betzold, Jonathan D. Edmonson, Michael L. Ellingson, Ben W. Herberg, Juliana E. Pronovici, James D. Reinke, Todd J. Sheldon, Paul R. Solheim
  • Publication number: 20210077815
    Abstract: An intracardiac ventricular pacemaker is configured to operate in in a selected one of an atrial-tracking ventricular pacing mode and a non-atrial tracking ventricular pacing mode. A control circuit of the pacemaker determines at least one motion signal metric from the motion signal, compares the at least one motion signal metric to pacing mode switching criteria, and, responsive to the pacing mode switching criteria being satisfied, switches from the selected one of the non-atrial tracking pacing mode and the atrial tracking pacing mode to the other one of the non-atrial tracking pacing mode and the atrial tracking pacing mode for controlling ventricular pacing pulses delivered by the pacemaker.
    Type: Application
    Filed: November 30, 2020
    Publication date: March 18, 2021
    Inventors: Todd J. SHELDON, Yong K. CHO, Wade M. DEMMER, Mark K. ERICKSON, Vincent E. SPLETT
  • Publication number: 20210052895
    Abstract: A medical device is configured to set a post-atrial time interval in response to an atrial event and generate an event time signal in response to a ventricular electrical signal crossing an R-wave sensing threshold during the post-atrial time interval. The device accumulates oversensing evidence in response to the event time signal and adjusts a ventricular sensing control parameter based on the accumulated oversensing evidence in some examples.
    Type: Application
    Filed: August 18, 2020
    Publication date: February 25, 2021
    Inventors: Maureen E. LYBARGER, Jian CAO, Wade M. DEMMER, Michael W. HEINKS, Jean E. HUDSON, Michael KEMMERER, James J. ST. MARTIN, Todd J. SHELDON
  • Publication number: 20200406041
    Abstract: A medical device is configured to sense a cardiac electrical signal and determine from the cardiac electrical signal at least one of a maximum peak amplitude of a positive slope of the cardiac electrical signal and a maximum peak time interval from a pacing pulse to the maximum peak amplitude. The device is configured to determine a capture type of the pacing pulse based on at least one or both of the maximum peak amplitude and the maximum peak time interval.
    Type: Application
    Filed: June 15, 2020
    Publication date: December 31, 2020
    Inventors: Jian CAO, Wade M. DEMMER, Maureen E. LYBARGER, Elizabeth A. MATTSON, Todd J. SHELDON, Zhongping YANG, Xiaohong ZHOU